Living with Parkinson’s or caring for someone in the later stages won’t be easy... it can be heart breaking.
As Parkinson’s disease progresses, symptoms become more complex and more debilitating.
There is an unmet medical need, and clinical research is important to get new safe and efficient drugs to the Parkinson’s disease field.
Participants in this research study will be closely monitored by a study doctor and will receive all study-related care at no cost to the participant. Compensation for travel may be available.
During the treatment period, a helpline will be available for subjects and study partners to call any time they encounter any difficulties. Home support will also be available.Find Out If You Or Your Loved One May Pre-qualify
About the Study
Parkinson's disease is a progressive neurological condition. It occurs when nerve cells, or neurons, in an area of the brain that controls movement become impaired and/or die. Normally these neurons produce an important brain chemical known as dopamine, which helps to regulate movement.
The purpose of this clinical research study is to investigate the efficacy, safety, and tolerability of continuous subcutaneous infusion of an investigational treatment in comparison to oral levodopa/carbidopa in patients with Parkinson’s disease.
To qualify for this study, individuals must:
- Be at least 30 years of age
- Have been diagnosed with Parkinson's Disease
- Currently be taking at least 4 doses a day of Levodopa or 3 doses a day of Rytary
- Currently experience at least 2.5 hours of “OFF” episodes a day
About Research Studies
In order to provide new medications to the public, pharmaceutical companies must test their investigational study drugs through clinical research studies (also called “clinical trials”).
The United States Food and Drug Administration (FDA) reviews the data collected in these studies before determining if a new medication can be approved for the public.
Study doctors are required to follow strict rules to protect the safety of the people who volunteer to participate in clinical trials.
All study staff must follow a detailed plan, called a protocol, which explains all study procedures and has been reviewed and approved by an independent board (or group of people) that oversees the safety and welfare of all study participants.
Additionally, before enrolling individuals into a study, study staff must fully explain the study to the individual and answer any questions he or she may have.
Participation in a clinical trial is voluntary, and participants may withdraw from the study at any time for any reason.
Find Out If You Or Your Loved One May Pre-qualify
Answer a short questionnaire to see if you or your loved one may pre-qualify for this research study. When you have finished please click SUBMIT.